FGB and cancer: Importantly, one specific peptide, produced by the cleavage of fibrinogen beta chain (FGB) was frequently identified as cancer biomarker in three previously published CE-MS studies, investigating bladder cancer, renal cell carcinoma and pancreatic cancer respectively13–15.